Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_assertion type Assertion NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_head.
- NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_assertion description "[, we can say that FV 1691 A and PT 20210 A mutations are important and must be included to the routine analysis of pediatric stroke patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_provenance.
- NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_assertion evidence source_evidence_literature NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_provenance.
- NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_assertion SIO_000772 11323021 NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_provenance.
- NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_assertion wasDerivedFrom gad-20130706 NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_provenance.
- NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_assertion wasGeneratedBy ECO_0000203 NP84298.RAYoDfLq-uHSSL1YJtxi9Lvn_WAjwQaFm_LIp8fMypdWA130_provenance.